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Introduction
Oxygen homeostasis is important for normal cellular function 
(Semenza, 2000). As oxygen levels decrease in the surrounding 
environment (hypoxia), cells respond by activating hypoxia-
inducible factor (HIF) dependent gene transcription to facilitate 
cellular adaptation to hypoxia. HIF is a heterodimer of two ba-
sic helix-loop-helix/Per/Arnt/Sim domain proteins, HIF-α and 
the aryl hydrocarbon nuclear translocator (ARNT or HIF-β; 
Wang et al., 1995). Under normal oxygen conditions, ARNT is 
constitutively stable, whereas the α subunit is labile. In normal 
oxygen conditions, the α subunit is hydroxylated at proline resi-
dues by a family of prolyl hydroxylase enzymes (PHDs). Pro-
line hydroxylation targets the protein for ubiquitination by the 
von Hippel-Lindau protein (pVHL)/E3 ubiquitin ligase and for 
subsequent proteasomal degradation (Maxwell et al., 1999; 
Bruick and McKnight, 2001; Epstein et al., 2001; Ivan et al., 
2001; Jaakkola et al., 2001). The α subunit is also hydroxylated 
at an asparagine residue by the enzyme factor inhibiting HIF-1 
(FIH-1) under normal oxygen conditions (Mahon et al., 2001; 
Lando et al., 2002a,b). Asparagine hydroxylation blocks the 
binding of the transcriptional coactivators p300 and CREB bind-
ing protein (CBP) to HIF-1 (Dames et al., 2002; Freedman et al., 
2002). Under hypoxic conditions, the α subunit is not hydroxyl-
ated by the PHDs or FIH, resulting in the stabilization of the 
HIF-α protein, dimerization with ARNT, and association with 
p300/CBP to initiate gene transcription.
The mechanism by which cells transduce the hypoxic sig-
nal to activate HIF is a subject of ongoing research. Previous 
studies indicate that mitochondria are involved in the transduc-
tion of hypoxic signals; however, the mechanism is not fully un-
derstood. One model proposes that mitochondria regulate the 
ability of the PHDs to hydroxylate HIF-1α protein because of 
their capacity to consume oxygen (Hagen et al., 2003; Doege 
et al., 2005). Mitochondrial oxygen consumption would generate 
a gradient of oxygen within the cytosol of the cell, thereby limiting 
the availability of oxygen, a necessary cosubstrate for PHD activ-
ity. Another model proposes that mitochondria increase the levels 
of cytosolic reactive oxygen species (ROS) during hypoxia to acti-
vate HIF (Bell et al., 2005). Initial evidence to support this model 
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ammalian cells increase transcription of genes 
for adaptation to hypoxia through the stabili-
zation of hypoxia-inducible factor 1α (HIF-1α) 
protein. How cells transduce hypoxic signals to stabilize 
the HIF-1α protein remains unresolved. We demonstrate 
that cells deﬁ  cient in the complex III subunit cytochrome b, 
which are respiratory incompetent, increase ROS levels 
and stabilize the HIF-1α protein during hypoxia. RNA 
  interference of the complex III subunit Rieske iron sulfur 
protein in the cytochrome b–null cells and treatment of 
wild-type cells with stigmatellin abolished reactive oxygen 
species (ROS) generation at the Qo site of complex III. 
These interventions maintained hydroxylation of HIF-1α 
protein and prevented stabilization of HIF-1α protein 
during hypoxia. Antioxidants maintained hydroxylation 
of HIF-1α protein and prevented stabilization of HIF-1α 
protein during hypoxia. Exogenous hydrogen peroxide 
under normoxia prevented hydroxylation of HIF-1α pro-
tein and stabilized HIF-1α protein. These results provide 
  genetic and pharmacologic evidence that the Qo site of 
complex III is required for the transduction of hypoxic 
signal by releasing ROS to stabilize the HIF-1α protein.
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came from observations that cells treated with mitochondrial 
electron transport inhibitors, and cells devoid of mitochondrial 
DNA (ρ
0 cells), fail to activate HIF during hypoxia because of a 
lack of mitochondrially generated ROS (Chandel et al., 1998, 
2000). Recently, three independent studies genetically confi  rmed 
the initial fi  nding that mitochondria-generated ROS are required 
for hypoxic activation of HIF. Cells devoid of the cytochrome c 
gene do not increase cytosolic ROS or stabilize HIF-1α in hy-
poxic conditions (Mansfi  eld et al., 2005). Cells with either tran-
sient or stable RNAi of the Rieske Fe-S protein, a component of 
the mitochondrial complex III (the bc1 complex), inhibits hypoxic 
increase of cytosolic ROS and stabilization of HIF-1α protein 
(Brunelle et al., 2005; Guzy et al., 2005).
Although these studies indicate that ROS generated within 
the mitochondrial electron transport chain are required to relay 
the hypoxic signal, they do not indicate which complex of the 
electron transport chain is the site of ROS generation. The mito-
chondrial electron transport chain generates superoxide at 
complexes I, II, and III (Turrens, 2003). Complexes I and II 
generate superoxide within the mitochondrial matrix (Turrens and 
Boveris, 1980; Turrens et al., 1982; Zhang et al., 1998; Genova 
et al., 2001; Lenaz, 2001; Kushnareva et al., 2002; Paddenberg 
et al., 2003). Complex III generates superoxide at the Qo site, 
resulting in the release of superoxide into either the intermem-
brane space or the matrix (Boveris et al., 1976; Cadenas et al., 
1977; Turrens et al., 1985; Han et al., 2001; Starkov and Fiskum, 
2001; Muller et al., 2004). Complex IV has not been reported 
to generate ROS; however, cytochrome c was recently demon-
strated to participate in the generation of hydrogen peroxide by 
providing electrons to p66 Shc (Giorgio et al., 2005). The obser-
vations that loss of cytochrome c gene or RNAi of the Rieske 
Fe-S protein prevent hypoxic stabilization of the HIF-1α pro-
tein implicate either complex III or cytochrome c as the source 
of ROS generation required for hypoxic stabilization of the 
HIF-1α protein. In the present study, we examined which site 
within the mitochondrial electron transport chain is required for 
the generation of ROS and hypoxic stabilization of the HIF-1α 
protein independently of respiration.
Results
Hypoxic stabilization of HIF-1𝗂 protein is 
independent of respiration and cytochrome b
Mitochondrial complex III consists of 11 subunits, three of 
which have known electron transport activity (the Rieske Fe-S 
protein, cytochrome b, and cytochrome c1). The electron fl  ux 
from ubiquinol (QH2) to cytochrome c occurs through the ubi-
quinone (Q) cycle within complex III (Hunte et al., 2003). The 
fi  rst electron from ubiquinol is transferred to the Rieske Fe-S/
cytochrome c1/cytochrome c axis transiently, making the radical 
ubisemiquinone. The second electron from ubisemiquinone is 
transferred to cytochrome b. However, ubisemiquinone does 
have the capability of transferring an electron to oxygen to gen-
erate superoxide. This allows for the generation of ROS at the 
Qo site of complex III through the interaction between ubisemi-
quinone (Q) and molecular oxygen within the bc1 complex (Fig. 
1 A). To explore the role of complex III in the stabilization of 
the HIF-1α protein, we used cells that are defi  cient in cyto-
chrome b. These cells are cybrids that were generated by repopu-
lating 143Bρ
0 cells with mitochondria that contain either a 
wild-type (WT) mitochondria DNA or a 4-base pair deletion of 
the cytochrome b gene (Rana et al., 2000). The cytochrome 
b–defi  cient cells (∆Cyt b) do not consume oxygen, similar to 
ρ
0 cells (Fig. 1 B). However, the ∆Cyt b cybrid cells retain the 
ability to stabilize HIF-1α protein under hypoxia (Fig. 1 C). 
These data indicate that the ability of cells to consume oxygen 
is not related to their ability to stabilize HIF-1α protein.
Moreover, under hypoxia, the ∆Cyt b cybrids increase 
H2O2 levels measured in the cytosol using Amplex red (Fig. 
1 D). ρ
0 cells did not display an increase in ROS in the cyto-
sol during hypoxia, indicating that mitochondria are the major 
source of ROS production during hypoxia. These data indi-
cate that that the ability of mitochondria to increase cytosolic 
ROS and stabilize HIF protein in hypoxia is independent of 
both cytochrome b and oxygen consumption. Additionally, 
the levels of cytosolic antioxidant proteins Cu/Zn superoxide 
dismutase and catalase did not change drastically in hypoxic 
Figure 1.  Cells that contain a cytochrome b  –deﬁ  cient bc1 complex 
are respiratory incompetent but still generate ROS and stabilize 
HIF-1𝗂 in hypoxia. (A) Mitochondrial complex III generates 
ROS through the ubiquinone (Q) cycle. The Q cycle generates 
ROS at the Qo and Qi site. The Rieske Fe-S protein is required 
for ROS production at the Qo site. The loss of complex III subunit 
cytochrome b abolishes the Qi site. (B) Oxygen consumption of 
143B cells, 143Bρ
0 cells, WT cybrids, and ∆Cyt b cybrids with 
and without 1 μM of the mitochondrial electron transport inhibitor 
stigmatellin. (C) HIF-1α protein levels in WT and ∆Cyt b cybrids 
subjected to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG (D) 
for 4 h. Representative blot from four independent experiments. 
(D) Intracellular H2O2 levels were measured by Amplex red in 143B 
cells, 143Bρ
0 cells, WT cybrids, and ∆Cyt b cybrids exposed to 
1.5 or 21% O2 for 4 h. n = 4 (mean ± SEM); *, P < 0.05 (all 
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conditions (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200609074/DC1). To determine whether mitochondrial 
ROS generation was responsible for the increase in cytosolic 
ROS and stabilization of the HIF-1α protein in the ∆Cyt b cy-
brids, these cells were treated with the mitochondrial-targeted 
antioxidant MitoQ. MitoQ abolished the increase in cytosolic 
ROS during hypoxia in the ∆Cyt b cybrids (Fig. 2 A). Hypoxic 
stabilization of the HIF-1α protein was diminished in both WT 
and ∆Cyt b cybrid cell lines treated with MitoQ but not in the 
presence of dimethyloxalylglycine (DMOG; Fig. 2, B and C). 
MitoQ diminished stabilization in a dose-dependent manner in 
both cell types (Fig. S2). These results are corroborated with 
the observation that EUK-134, a mimetic of both catalase and 
superoxide dismutase, inhibits hypoxic stabilization of HIF-1α 
protein in both the WT and the ∆Cyt b cybrids (Fig. 3).
Hypoxic stabilization of HIF-1𝗂 protein 
requires generation of ROS from the Qo 
site of the mitochondrial complex III
To further validate that the mitochondrial electron transport 
chain is required for hypoxic stabilization of the HIF-1α protein 
in the ∆Cyt b cybrids, we used short hairpin RNA (shRNA) 
against the mitochondrial transcription factor A (TFAM). TFAM is 
required for the proper transcription and replication of mito-
chondrial DNA (Ekstrand et al., 2004). In the absence of TFAM, 
cells become depleted of their mitochondrial DNA (ρ
0 cells; 
Larsson et al., 1998). Expression of TFAM shRNA in the ∆Cyt 
b cybrids lowered TFAM mRNA expression and mitochondrial 
copy number by 75% compared with cells expressing the con-
trol shRNA against Drosophila melanogaster HIF (dHIF; Fig. 
4, A and B). The cell containing TFAM shRNA diminished their 
ability to stabilize HIF-1α protein under hypoxia (Fig. 4 C). 
These data indicate that mitochondrial electron transport has an 
important role in hypoxic stabilization of HIF-1α protein.
To determine whether ROS generation from the Qo site is 
responsible for the increase in cytosolic ROS and stabilization 
of the HIF-1α protein, the ∆Cyt b cybrid cells were stably in-
fected with retrovirus containing shRNA against the Rieske Fe-S 
protein. In the absence of the Rieske Fe-S protein, the Q cycle 
is not initiated and ROS are not generated at the Qo site. It is 
theoretically possible that the Qi site might generate ROS. How-
ever, activity of the Qi site is abolished in cells defi  cient in the 
cytochrome b protein (Fig. 1). Therefore, the data indicate that 
the Qi site is dispensable for hypoxic increase in cytosolic ROS 
and stabilization of HIF-1α. Stably expressing a shRNA against 
the Rieske Fe-S protein in the ∆Cyt b cybrid cells decreases 
expression of the Rieske Fe-S protein (Fig. 5 A). These cells do 
not stabilize the HIF-1α protein when exposed to hypoxia but 
retain HIF-1α protein stabilization in the presence of DMOG 
(Fig. 5 B). As expected, neither the TFAM shRNA cells nor 
Rieske Fe-S shRNA cells were able to increase cytosolic ROS 
under hypoxic conditions (Fig. 5 C).
To ensure that our results were not due to any adaptation 
to the loss of cytochrome b protein or shRNA against Rieske 
Fe-S protein, we corroborated our genetic fi  ndings in WT cells 
using well-established pharmacological inhibitors of complex 
III. Incubating WT cells with the complex III inhibitor stig-
matellin, which binds to the Qo site, inhibits hypoxic stabiliza-
tion of HIF-1α protein (Fig. 6 A). In contrast, the complex III 
inhibitor antimycin A, which preserves the ROS generation at 
the Qo site of complex III, did not decrease hypoxic stabilization 
Figure 2.  Mitochondrial-targeted antioxidant MitoQ prevents hypoxic 
stabilization of HIF-1𝗂 protein. (A) Intracellular H2O2 levels were measured 
in ∆Cyt b cybrids using Amplex red in the presence of 1 μM MitoQ or 
1 μM of the control compound TPMP for 4 h. n = 4 (mean ± SEM); *, P < 
0.05 (TPMP hypoxia samples compared with MitoQ hypoxia samples). 
(B and C) HIF-1α protein levels of whole cell lysates from ∆Cyt b cybrids 
(B) and WT cybrids (C) preincubated with 1 μM MitoQ or 1 μM of the 
control compound TPMP for 4 h and then subjected to 21% O2 (N), 1.5% 
O2 (H), or 1 mM DMOG (D) for 4 h. Representative blot from four indepen-
dent experiments.
Figure 3.  Cytosolic antioxidant EUK-143 prevents hypoxic stabilization of 
HIF-1𝗂 protein. HIF-1α protein levels of whole cell lysates from WT cybrids 
(A) and ∆Cyt b cybrids (B) preincubated with 10 μM EUK-134 for 2 h and 
then subjected to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG (D) for 4 h. 
Representative blot from three independent experiments.JCB • VOLUME 177 • NUMBER 6 • 2007  1032
of HIF-1α in the WT cybrids (Fig. 6 B). Collectively, these data 
implicate the Qo site of complex III as the primary site of ROS 
generation for hypoxic stabilization of HIF-1α protein.
ROS regulate hydroxylation 
of HIF-1𝗂 protein
Under normal oxygen conditions, HIF-1α protein is hydroxyl-
ated by the PHDs, thereby facilitating ubiquitination and sub-
sequent proteasomal degradation. Exogenous ROS are suffi  cient 
to stabilize HIF-1α protein under normal oxygen conditions 
(Chandel et al., 2000). Using an antibody that specifi  cally rec-
ognizes HIF-1α protein hydroxylated on proline 564, we dem-
onstrate that ROS inhibit the ability of the PHDs to hydroxylate 
HIF-1α protein. Quenching the increase in cytosolic ROS under 
hypoxia with MitoQ recovers hydroxylation of HIF-1α protein 
in both the WT and ∆Cyt b cybrids (Fig. 7). To test whether 
exogenous ROS are suffi  cient to prevent hydroxylation of the 
HIF-1α protein, cells were exposed to glucose oxidase, an enzyme 
that generates H2O2. Addition of 10 μg/ml glucose oxidase 
increases intracellular ROS to levels that are similar to those 
measured in hypoxic conditions (Fig. 8 A). These levels of ROS 
generated in normal oxygen conditions are suffi  cient to stabilize 
HIF-1α protein (Fig. 8 B). Addition of the antioxidant protein 
catalase in this experiment inhibits stabilization of HIF-1α pro-
tein, indicating that H2O2 is responsible for the stabilization of 
the HIF-1α protein. The presence of glucose oxidase attenuates 
hydroxylation of HIF-1α protein, as assessed by reactivity with 
the hydroxylation-specifi  c antibody (Fig. 8 C). The addition of 
catalase in the presence of glucose oxidase under normal oxygen 
conditions recovers hydroxylation of HIF-1α protein, indicating 
that the ability of the PHDs to hydroxylate HIF-1α protein is 
indeed regulated by ROS.
Cytochrome c reduction is not sufﬁ  cient 
to stabilize HIF under hypoxia
Previous fi  ndings indicate that loss of cytochrome c prevents 
the hypoxic stabilization of the HIF-1α protein (Mansfi  eld et al., 
2005). To determine whether cytochrome c–generated ROS are 
required for the hypoxic stabilization of the HIF-1α protein, 
we exposed ρ
0 cells to normoxia or hypoxia in the presence of 
N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD). ρ
0 cells 
lack a functional complex III and IV, resulting in a loss of elec-
tron fl  ux through cytochrome c. TMPD donates electrons to cyto-
chrome c, thereby fully reducing cytochrome c. The electrons 
from cytochrome c could then be donated to p66 Shc in the 
absence of a functional complex IV, resulting in ROS genera-
tion and HIF stabilization. WT 143B or A549 cells stabilize the 
HIF-1α protein during hypoxia (1.5% O2) or in the presence of 
DMOG (Fig. 9 A). In contrast, the 143Bρ
0 or A549ρ
0 cells do 
not stabilize HIF-1α protein during hypoxia. The addition of 
Figure 4.  RNAi of TFAM diminishes hypoxic stabilization of HIF-1𝗂 protein. 
Quantitative real-time PCR of cDNA (A) or total DNA (B) generated from 
∆Cyt b cybrids stably expressing shRNA for D. melanogaster HIF (dHIF) 
or TFAM. n = 3 (mean ± SEM); *, P < 0.05 (dHIF shRNA compared with 
TFMA shRNA). (C) HIF-1α protein levels from whole cell lysates of ∆Cyt b 
cybrids stably expressing shRNA for either D. melanogaster HIF (dHIF) or 
TFAM, exposed to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG (D) for 4 h. 
Representative blot from three independent experiments.
Figure 5.  Electron transfer at the Qo site of the bc1 complex is necessary 
for hypoxic generation of ROS and stabilization of HIF-1𝗂 protein. (A) Immuno-
blot analysis for Rieske Fe-S protein of whole cell lysates from ∆Cyt b 
cybrids stably expressing shRNA for D. melanogaster HIF (dHIF), TFAM, or 
Rieske Fe-S protein (FE-S) at 21% O2. (B) HIF-1α protein levels from whole 
cell lysates of ∆Cyt b cybrids stably expressing shRNA against either 
D. melanogaster HIF (dHIF) or Rieske Fe-S protein (FE-S) exposed to 21% O2 
(N), 1.5% O2 (H), or 1 mM DMOG (D) for 4 h. Representative blot from 
four independent experiments. (C) Intracellular H2O2 levels measured with 
Amplex red in ∆Cyt b cybrids stably expressing shRNA for D. melanogaster 
HIF, TFAM, or Rieske Fe-S protein exposed to either 21 or 1.5% O2 for 4 h. 
n = 4 (mean ± SEM); *, P < 0.05 (hypoxic dHIF shRNA compared with 
hypoxic TFMA shRNA and hypoxic Rieske Fe-S shRNA).MITOCHONDRIAL COMPLEX III REGULATES HYPOXIC SIGNALING • BELL ET AL. 1033
TMPD to either 143Bρ
0 or A549ρ
0 cells also did not stabilize 
the HIF-1α protein under normoxia (21% O2) or hypoxia (1.5% 
O2; Fig. 9 B). This was not due to reduced levels of p66Shc 
or cytochrome c in the ρ
0 cells (Fig. 9 C). TMPD did reduce 
cytochrome c, and under these conditions it did not generate 
ROS (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200609074/DC1). Previous results indicate that ROS due to 
electron transfer between cytochrome c and p66shc is observed 
only during DNA damage and may not be the normal physi-
ological response in healthy cells (Giorgio et al., 2005). These 
results indicate that reduction of cytochrome c is not suffi  cient 
for hypoxic stabilization of HIF-1α protein.
Discussion
Mammalian cells transduce signals that couple decreases in 
oxygen levels to initiate HIF-dependent gene expression. The 
mechanism of how cells transduce hypoxic signals is not fully 
understood. Mitochondrial electron transport chain has been 
proposed as part of the hypoxic signal transduction machinery. 
Indeed, previous genetic evidence indicates that loss of cyto-
chrome c or the Rieske Fe-S protein prevents the hypoxic stabi-
lization of HIF-1α, indicating that these proteins are involved in 
the increase in cytosolic ROS during hypoxia (Brunelle et al., 
2005; Guzy et al., 2005; Mansfi  eld et al., 2005). RNAi of the 
Rieske Fe-S protein or loss of cytochrome c prevents the forma-
tion of ubisemiquinone, thus preventing ROS generation at the 
Qo site of complex III. The loss of cytochrome c or RNAi of 
Rieske Fe-S protein would also not cause a reduction in cyto-
chrome c, thereby preventing cytochrome c–dependent ROS 
generation. In the present study, we demonstrate that cytochrome c 
is not the primary site of ROS generation in hypoxia. We dem-
onstrate that fully reducing cytochrome c levels is not suffi  cient 
to stabilize the HIF-1α protein during hypoxia or normoxia. 
Therefore, cytochrome c does not contribute to hypoxic signal 
transduction through its ability to generate ROS via p66Shc.
Our data indicate that the Qo site of complex III is part of 
the hypoxic signal transduction machinery. Cells defi  cient in 
cytochrome b protein are able to generate ROS at the Qo site of 
complex III. During hypoxia, these cells stabilize the HIF-1α 
protein. Preventing ROS generation at the Qo site in the cyto-
chrome b–defi  cient cells with MitoQ or by shRNA against the 
Rieske Fe-S protein prevents the increase in cytosolic ROS and 
stabilization of the HIF-1α protein during hypoxia. The present 
data also demonstrate that ROS regulate the ability of the PHDs 
to hydroxylate HIF in both normoxic and hypoxic conditions. 
Quenching ROS with MitoQ in hypoxic conditions allows for 
continued hydroxylation of HIF-1α protein, whereas addition 
of exogenous ROS in normal oxygen conditions inhibits the abil-
ity of the PHDs to hydroxylate HIF-1α protein. These data sug-
gest that the Qo site of the bc1 complex participates in hypoxic 
signal transduction via ROS generation to initiate HIF-mediated 
transcriptional responses that facilitate cellular adaptation to 
low oxygen.
The present data are in contrast with other groups that 
have proposed that the ability of mitochondria to consume oxy-
gen is the major requirement for stabilization of the HIF-1α pro-
tein in hypoxic conditions. Their model proposes that respiring 
mitochondria generate an oxygen gradient, preventing hydrox-
ylation, and thereby increasing stabilization of the HIF-1α pro-
tein (Hagen et al., 2003; Doege et al., 2005). According to this 
model, in the absence of a functioning respiratory chain, the 
oxygen gradient would be reduced, resulting in hydroxylation 
and degradation of the HIF-1α protein. However, the cytochrome 
b–null cells are respiratory incompetent and therefore unable to 
generate an oxygen gradient. Contrary to this model, these cells 
still retain the ability to stabilize the HIF-1α protein during 
hypoxia. Furthermore, the mitochondrial-targeted antioxidant 
MitoQ or the cytosolic antioxidant EUK-134 prevents stabilization 
of the HIF-1α protein in the cytochrome b–defi  cient cells, indi-
cating ROS involvement in HIF stabilization. MitoQ has been 
shown to prevent hypoxic stabilization of the HIF-1α protein in 
Figure 6. Hypoxic  HIF-1𝗂 protein stability is attenuated by pharmacol-
ogical inhibitors of the Qo but not Qi site in WT cells. (A) HIF-1α protein levels 
of whole cell lysates from WT cybrids incubated with 1 μM stigmatellin 
and subjected to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG (D) for 4 h. 
Representative blot from three independent experiments. (B) HIF-1α protein 
levels of whole cell lysates from WT cybrids incubated with 1 μM anti-
mycin A and subjected to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG (D) 
for 4 h. Representative blot from three independent experiments.
Figure 7.  Hypoxic increase in cytosolic ROS generated from the Qo site of 
complex III inhibits hydroxylation of HIF-1𝗂 protein. Immunoblot analysis 
of whole cell lysates for hydroxylated HIF-1α protein from WT cybrids (A) 
and ∆Cyt b cybrids (B) treated with 20 μM MG132 to stabilize HIF-1α 
protein preincubated with 1 μM MitoQ or 1 μM control compound TPMP 
for 4 h and then subjected to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG 
(D) for 4 h. Representative blot from three independent experiments.JCB • VOLUME 177 • NUMBER 6 • 2007  1034
respiratory-competent cells, demonstrating the importance of 
ROS in HIF-1α protein stabilization (Sanjuan-Pla et al., 2005). 
However, there are instances when an oxygen gradient created 
by the mitochondria during normoxia can create a hypoxic 
environment within cells, causing HIF-1α protein accumulation 
(Doege et al., 2005). For example, if metabolically active cells 
are cultured at high confl  uency, their demand for oxygen ex-
ceeds the supply of oxygen, resulting in a local hypoxia. Under 
these conditions, respiratory inhibition would result in restora-
tion of the oxygen levels to normoxia within the cells, resulting 
in the degradation of the HIF-1α protein. Cells that are cultured 
at a high confl  uency under hypoxia (1–2% O2) would experi-
ence anoxia (0% O2). Under these conditions, respiratory inhibi-
tion would result in restoration of oxygen levels only to the 
hypoxic levels. If respiratory inhibition does not result in attenu-
ating ROS generation, such as in the cytochrome b–defi  cient 
cells, then cells would still be able to stabilize the HIF-1α pro-
tein in conditions of high confl  uency under hypoxia. Collectively, 
our data indicate that the ability of mitochondria to generate 
ROS and not an oxygen gradient is required for the stabilization 
of the HIF-1α protein during hypoxia.
In summary, we demonstrate that the Qo site of complex 
III is necessary to increase cytosolic ROS in hypoxic condi-
tions, which results in the inhibition of the ability of the PHDs 
to initiate degradation of HIF-1α protein (Fig. 10). We also con-
clusively demonstrate that the ability to consume oxygen by 
mitochondria is not required for hypoxic stabilization of the 
HIF-1α protein. The link between ROS and the PHDs is cur-
rently unknown. As oxygen levels fall, the enzymatic activity of 
PHDs decrease (Schofi  eld and Ratcliffe, 2004). It is possible 
that the link could be an oxidant-dependent signaling pathway 
in which a posttranslational modifi  cation of the PHDs, such as 
phosphorylation, turns off the catalytic activity. In fact previous 
studies have implicated multiple signaling molecules that are 
required for hypoxic activation of HIF-1 (Aragones et al., 2001; 
Hirota and Semenza, 2001; Turcotte et al., 2003; Emerling et al., 
2005; Hui et al., 2006). Alternatively, the link between ROS and 
the PHDs could be due to changes in the cytosolic redox state. 
The ROS may induce a shift in iron redox state from Fe
+2 to 
Fe
+3 as a result of the Fenton reaction, thereby limiting an essential 
cofactor of the PHDs, resulting in an inhibition of hydroxyl-
ation of HIF protein (Gerald et al., 2004). It could also be that 
the low oxygen levels decrease PHD activity and the ROS pro-
duced during hypoxia further decrease PHD activity to prevent 
hydroxylation of HIF-α protein. Furthermore, multiple factors 
affecting cellular redox state and metabolism are likely to affect 
hydroxylation of the HIF-1α protein (Pan et al., 2006). Our 
study also suggests that the targeting of mitochondrial ROS 
could serve as a therapeutic target for many HIF-dependent 
pathological processes, including cancer. It will be of interest 
in future studies to examine whether the Qo site of complex III 
serves as part of a signal transduction machinery for other 
  hypoxia-initiated cellular events, such as calcium signaling.
Figure 8.  ROS are sufﬁ  cient to prevent hydroxylation of HIF-1𝗂 protein. 
(A) Intracellular ROS measured by DCFH in WT cybrids subjected to 21% 
O2 (N), 1.5% O2 (H), 21% O2 plus glucose oxidase (10 μg/ml), or 21% 
O2 plus glucose oxidase and catalase for 2 h. n = 4 (mean ± SEM); *, P < 
0.05 (normoxia compared with hypoxia or normoxia + glucose oxidase 
compared with normoxia + glucose oxidase + catalase). (B) Immunoblot 
analysis of whole cell lysates for HIF-1α protein from WT cybrids subjected 
to 21% O2 (N), 1.5% O2 (H), 21% O2 plus glucose oxidase, or 21% O2 
plus glucose oxidase and catalase for 2 h. Representative blot from three 
independent experiments. (C) Immunoblot analysis for hydroxylated HIF-1α 
protein from whole cell lysates of WT cybrids treated with 20 μM MG132 
subjected to 21% O2 (N), 1.5% O2 (H), 21% O2 plus glucose oxidase, or 
21% O2 plus glucose oxidase and catalase for 2 h. Representative blot 
from three independent experiments.
Figure 9. Reduced  cytochrome  c is not sufﬁ  cient to stabilize the HIF-1𝗂 
protein. (A) HIF-1α protein levels of 143B and A549 cells subjected to 
21% O2 (N), 1.5% O2 (H), and 1 mM DMOG (D) for 2 h. Representative 
blot from three independent experiments. (B) HIF-1α protein levels of 
143Bρ
0 and A549ρ
0 whole cell lysates <21% O2 (N) or 1.5% O2 (H) for 
2 h after a 15-min pulse of 100 μM of the cytochrome c–reducing agent 
TMPD and 400 μM ascorbate (T) or 1 mM DMOG (D). Representative blot 
from three independent experiments. (C) Cytochrome c and p66Shc pro-
tein levels in 143Bρ
0 and A549ρ
0 whole cell lysates. Representative blot 
from three independent experiments.MITOCHONDRIAL COMPLEX III REGULATES HYPOXIC SIGNALING • BELL ET AL. 1035
Materials and methods
Cell culture
WT A549 and 143B cells were cultured in DME, whereas the ρ
0 deriva-
tives were cultured in DME supplemented with 100 μg/ml uridine. The ρ
0 
derivatives were made as previously described (Brunelle et al., 2005). The 
WT and ∆Cyt b 143B cybrid cells (provided by I.F.M. de Coo, University 
Medical Center, Rotterdam, Rotterdam, Netherlands) were previously de-
scribed by Rana et al. (2000) and were cultured in DME supplemented 
with 100 μg/ml uridine. Cells were cultured at 37°C in 5% CO2 humidiﬁ  ed 
incubators for normoxic conditions. Hypoxic conditions (1.5% O2) were 
achieved in the humidiﬁ  ed variable aerobic workstation InVivo2 (Biotrace). 
Glucose oxidase, catalase, stigmatellin, and antimycin A were purchased 
from Sigma-Aldrich.
RNAi in cytochrome b–null cells
The pSiren retroviral vector (CLONTECH Laboratories, Inc.) was used to ex-
press shRNA sequences for the Rieske Fe-S (5′-A  A  G  G  T  G  C  C  T  G  A  C  T  T  C  T  C  T-
G  A  A   -3′), TFAM (5′-G  T  T  G  T  C  C  A  A  A  G  A  A  A  C  C  T  G  T  -3′), and D. melanogaster 
HIF (5′-G  C  C  T  A  C  A  T  C  C  C  G  A  T  C  G  A  T  G  A  T  G  -3′). Stable lines were gener-
ated using retroviral infection methods with the PT67 packaging cell line 
(CLONTECH Laboratories, Inc.).
ROS measurement
Intracellular ROS was measured using Amplex red (Invitrogen) according 
to manufacturer’s protocol. In brief, cells were lysed in 100 μM Amplex 
red solution supplemented with 2 U/ml HRP and 200 mU/ml superoxide 
dismutase (OXIS International) and incubated in the dark for 30 min. Fluor-
escence was measured in a plate reader (SpectraMax Gemini; Molecular 
Devices) with excitation of 540 nm and emission of 590 nm. Alternatively, 
ROS were measured using 10 μM of the oxidant-sensitive ﬂ  uorescent 
probe 5-(and-6)-chloromethyl-2’,7’-dichlorodihydroﬂ  uorescein diacetate 
acetyl ester (CM-H2DCFDA; Invitrogen). Cells were plated at equal density 
in 60-mm plates. The next day, cells were incubated continuously with 
CM-H2DCFDA for 2 h and exposed to different experimental conditions. 
Sub  sequently, cells were washed and lysed in 0.1% Triton X-100. Fluores-
cence was measured in the SpectraMax Gemini plate reader with excita-
tion of 488 nm and emission of 530 nm.
Real-time RT-PCR
Total RNA was isolated using the Aurum Mini kit (Bio-Rad Laboratories), and 
cDNA was generated using the RNAqueous-4PCR system (Ambion) according 
to manufacturer’s protocol. Prepared cDNA was analyzed for TFAM mRNA 
using SYBR Green Master Mix (Bio-Rad Laboratories). Cycle threshold (Ct) 
values for TFAM were normalized to Ct values for ribosomal protein L19, 
and data were analyzed using the Pfafﬂ    (2001) method. Primers used 
were as follows: TFAM, 5′-A  A  G  A  T  T  C  C  A  A  G  A  A  G  C  T  A  A  G  G  G  T  G  A  -3′ and 
5′-C  A  G  A  G  T  C  A  G  A  C  A  G  A  T  T  T  T  T  C  C  A  G  T  T  T  -3′; and RPL19, 5′-G  T  A  T  G  C  T  C  A-
G  G  C  T  T  C  A  G  A  A  G  A  -3′ and 5′-C  A  T  T  G  G  T  C  T  C  A  T  T  G  G  G  G  T  C  T  A  A  C  -3′.
Immunoblotting
Protein levels were analyzed in whole cell lysates obtained using lysis 
buffer (Cell Signaling), and 50 μg of samples were resolved on a SDS 
polyacrylamide gel. Gels were analyzed by immunoblotting with antibod-
ies for HIF-1α, cytochrome c, p66Shc (BD Biosciences), Rieske Iron Sulfur 
protein (Invitrogen), and hydroxylated HIF-1α (a gift from P. Ratcliffe, Univer-
sity of Oxford, Oxford, UK), and α-tubulin (Sigma-Aldrich) was used as a 
loading control.
Oxygen consumption
Cellular O2 consumption rates were measured in aliquots of 1–3 × 10
6 
subconﬂ   uent cells removed from ﬂ   asks and studied in a magnetically 
stirred, water-jacketed (37°C) anaerobic respirometer ﬁ  tted with a polaro-
graphic O2 electrode (Oxytherm system; Hansatech Instruments). Oxygraph 
Plus software was used to determine oxygen consumption rate.
Mitochondrial copy number assay
The number of mitochondria was determined by analyzing the abundance 
of the mitochondrial DNA encoded gene cytochrome c oxidase subunit 1 
(COX1) relative to the nuclear gene 18S. Total DNA was isolated using 
the DNEasy Tissue kit (QIAGEN). 10 ng of total DNA was subjected to 
quantitative Real-Time PCR using Sybr Green Chemistry. Primers used 
were as follows: 18S forward, 5′-A  C  A  G  G  A  T  T  G  A  C  A  G  A  T  T  G  A  T  A  G  C  T  C  -3′;
18S reverse, 5′-C  A  A  A  T  C  G  C  T  C  C  A  C  C  A  A  C  T  A  A  G  A  A  -3′; COX1 forward, 
5′-C  C  C  A  C  C  G  G  C  G  T  C  A  A  A  G  T  A  T  T  -3′; and COX1 reverse, 5′-T  T  T  G  C  T  AATA-
C  A  A      T  G  C  C  A  G  T  C  A  G  G  -3′.
Statistical analysis
The data presented are means ± SEM. Data were analyzed by two-way 
analysis of variance using Graph Pad Prism 4. When the analysis of vari-
ance indicated a signiﬁ  cant difference, individual differences were ex-
plored with paired t test. Statistical signiﬁ  cance was determined at the 
0.05 level.
Online supplemental material
Fig. S1 shows antioxidant protein proﬁ  le of whole cell lysates from WT 
cybrids and ∆Cyt b cybrids subjected to either 21% O2 (N) or 1.5% O2 (H) 
for 4 h. Fig. S2 shows HIF-1α protein levels in WT and ∆Cyt b cybrids sub-
jected to 21% O2 (N), 1.5% O2 (H), or 1 mM DMOG (D) for 4 h at various 
concentrations of MitoQ. Fig. S3 shows ρ
0 cells treated with TMPD/ascorbate 
for 15 min and then subjected to either 21 or 1.5% O2; cytochrome redox 
state in isolated mitochondria or ROS measurement via DCFH oxidation 
was then assessed in whole cells. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200609074/DC1.
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